Diabetes (eBook, PDF)
Translating Research into Practice
Redaktion: Greenbaum, Carla J.; Harrison, Leonard C.
59,95 €
59,95 €
inkl. MwSt.
Sofort per Download lieferbar
30 °P sammeln
59,95 €
Als Download kaufen
59,95 €
inkl. MwSt.
Sofort per Download lieferbar
30 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
59,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
30 °P sammeln
Diabetes (eBook, PDF)
Translating Research into Practice
Redaktion: Greenbaum, Carla J.; Harrison, Leonard C.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Diabetes has garnered worldwide attention and research funding as clinicians and researchers seek to better understand its pathogenesis, prevention, complications management, and impact and relationship to other diseases (heart disease, kidney disease, infections, and inflammation). Clinicians are overwhelmed with rapidly evolving developments rega
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 2.39MB
Andere Kunden interessierten sich auch für
Experimental Models of Diabetes (eBook, PDF)118,95 €
Hypertension in Diabetes (eBook, PDF)52,95 €
Geriatric Diabetes (eBook, PDF)58,95 €
Burton E. SobelMedical Management of Diabetes and Heart Disease (eBook, PDF)113,95 €
Janet TitchenerDiabetes Management (eBook, PDF)41,95 €
Ian N. ScobieAtlas of Diabetes Mellitus (eBook, PDF)76,95 €
Obesity and Mental Disorders (eBook, PDF)61,95 €-
-
-
Diabetes has garnered worldwide attention and research funding as clinicians and researchers seek to better understand its pathogenesis, prevention, complications management, and impact and relationship to other diseases (heart disease, kidney disease, infections, and inflammation). Clinicians are overwhelmed with rapidly evolving developments rega
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis eBooks
- Seitenzahl: 248
- Erscheinungstermin: 18. August 2008
- Englisch
- ISBN-13: 9781420047363
- Artikelnr.: 42765971
- Verlag: Taylor & Francis eBooks
- Seitenzahl: 248
- Erscheinungstermin: 18. August 2008
- Englisch
- ISBN-13: 9781420047363
- Artikelnr.: 42765971
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
CARLA J. GREENBAUM is director of the Diabetes Program and the Clinical Research Center at Benaroya Research Institute, Seattle, Washington, USA. She received her MD from Brown University, Providence, Rhode Island, USA. Dr. Greenbaum has been a leader in clinical investigations and trials to prevent or intervene with the diabetes autoimmune process, contributing to over 100 book chapters, abstracts, and journals. She currently serves as Vice-Chair of Type 1 Diabetes TrialNet, an NIH sponsored international consortium to conduct multiple clinical trials in Type 1 diabetes, Director of the North American Network of the Type 1 Diabetes Genetics Consortium (NIH), and as a member of the Clinical Trials Advisory Group and Scientific Review Committee of the NIH sponsored Immune Tolerance Network. Dr. Greenbaum is a member of the Board of Directors of the Diabetes Vaccine Development Center (Australia) and the Clinical Affairs Advisory Committee for JDRF, as well as serving on many review committees focused on clinical and translational research. LEONARD C. HARRISON is Head of the Division of Autoimmunity and Transplantation at The Walter and Eliza Hall Institute of Medical Research, and Professor/Director of The Burnet Clinical Research Unit and Department of Clinical Immunology, The Royal Melbourne Hospital, Parkville, Victoria, Australia. He graduated in medicine from the University of New South Wales, Sydney, and obtained his M.D. and D.Sc from the University of Melbourne, Australia. He has been awarded various honors, including the Wellcome Glaxo Australia Medal and the David Rumbough Award from the Juvenile Diabetes Research Foundation International. Dr. Harrison has been Chairman of the Professional Advisory Panel of the Juvenile Diabetes Foundation Australia, President of the Australian Diabetes Society and President of the Immunology of Diabetes Society. He holds nine patents and has contributed to 450 original refereed papers, reviews, books, b
Problems with the definition of diabetes: closing the gap between type 1
and type 2. How do we screen for and predict autoimmune diabetes? How do we
screen for and predict autoimmune diabetes? How do we screen for and
predict non-autoimmune diabetes? How do we screen for and predict
non-autoimmune diabetes? What are the prospects for preventing autoimmune
diabetes? How can we use genetic information in the clinic? Neural and
endocrine control of satiety and energy metabolism. Insulin resistance; new
approaches to detection and treatment. Adipokines. Incretins. Retinopathy.
Cardiovascular disease. Transplantation. Creation and generation of B
cells. Technologies for insulin delivery and glucose monitoring. Diabetes
Complications: Molecules to Management.
and type 2. How do we screen for and predict autoimmune diabetes? How do we
screen for and predict autoimmune diabetes? How do we screen for and
predict non-autoimmune diabetes? How do we screen for and predict
non-autoimmune diabetes? What are the prospects for preventing autoimmune
diabetes? How can we use genetic information in the clinic? Neural and
endocrine control of satiety and energy metabolism. Insulin resistance; new
approaches to detection and treatment. Adipokines. Incretins. Retinopathy.
Cardiovascular disease. Transplantation. Creation and generation of B
cells. Technologies for insulin delivery and glucose monitoring. Diabetes
Complications: Molecules to Management.
Problems with the definition of diabetes: closing the gap between type 1
and type 2. How do we screen for and predict autoimmune diabetes? How do we
screen for and predict autoimmune diabetes? How do we screen for and
predict non-autoimmune diabetes? How do we screen for and predict
non-autoimmune diabetes? What are the prospects for preventing autoimmune
diabetes? How can we use genetic information in the clinic? Neural and
endocrine control of satiety and energy metabolism. Insulin resistance; new
approaches to detection and treatment. Adipokines. Incretins. Retinopathy.
Cardiovascular disease. Transplantation. Creation and generation of B
cells. Technologies for insulin delivery and glucose monitoring. Diabetes
Complications: Molecules to Management.
and type 2. How do we screen for and predict autoimmune diabetes? How do we
screen for and predict autoimmune diabetes? How do we screen for and
predict non-autoimmune diabetes? How do we screen for and predict
non-autoimmune diabetes? What are the prospects for preventing autoimmune
diabetes? How can we use genetic information in the clinic? Neural and
endocrine control of satiety and energy metabolism. Insulin resistance; new
approaches to detection and treatment. Adipokines. Incretins. Retinopathy.
Cardiovascular disease. Transplantation. Creation and generation of B
cells. Technologies for insulin delivery and glucose monitoring. Diabetes
Complications: Molecules to Management.







